Study finds Moderna boosts neutralising antibodies against Omicron

Moderna said its preliminary data looking at Omicron was ‘reassuring’ (Leon Neal/PA)

A dose of the Moderna vaccine used in the UK’s booster programme increases neutralising antibodies against Omicron around 37-fold, the firm has announced.

Moderna said its preliminary data looking at Omicron was “reassuring”, though it will continue to develop a jab specific to the variant.